Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
And your first question comes from the line of Stephen Reitman from Societe Generale.
Finally, Societe Generale assumed coverage on argenx in a report on Thursday, June 15th.
Source: https://www.dailypolitical.com/2023/07/27/argenx-nasdaqargx-downgraded-to-neutral-at-ubs-group.html
Finally, Societe Generale lowered their target price on Akzo Nobel from €100.00 ($106.38) to €84.00 ($89.36) in a research note on Wednesday, November 16th.
Source: https://www.dailypolitical.com/2022/12/31/akzo-nobel-otcmktsakzoy-short-interest-update.html
French media said the banks searched included HSBC, BNP Paribas, Exane -- a subsidiary of BNP -- Societe Generale, and Natixis.
Source: https://www.euronews.com/2023/03/29/five-french-banks-raided-in-alleged-tax-fraud-investigation
Once Societe Generale unit ALD completes its purchase of Dutch rival LeasePlan, it will have a fleet of 3.3 million vehicles.
Societe Generale cut their price target on shares of Alphabet from $147.00 to $132.00 and set a “buy” rating on the stock in a research report on Wednesday, November 30th.
Societe Generale downgraded shares of ASML from a “buy” rating to a “hold” rating in a report on Friday, July 21st.
Societe Generale has confirmed the investigation at its office but declined to comment further.
Societe Generale increased their target price on shares of Raiffeisen Bank International from €13.40 ($14.57) to €14.80 ($16.09) and gave the company a “hold” rating in a research report on Friday, November 4th.
Societe Generale upgraded ConocoPhillips from a “sell” rating to a “hold” rating and set a $105.00 target price for the company in a report on Wednesday, April 5th.
Societe Generale upgraded shares of Coca-Cola HBC from a “sell” rating to a “hold” rating in a report on Friday, August 25th.
The pivotal clinical trial results have been selected as a "late-breaking abstract" for the 43rd Congress of the Societe Internationale d'Urologie (SIU) in Istanbul, Turkey, this month.